speb/financial-data huggingface dataset:
Financial ratios for AMH — annual report dated 2023-12-31
Total revenue: 1623605000
Gross profit: 900783000
Operating income: 369618000
Net income: 432142000
Capital expenditures: 134176000
Operating cash flow: 738689000
Depreciation & amortization: 456550000
Net tangible assets: 6847245000
Owner earnings: 754516000
Return on net tangible assets (%): 11.019263952144257
Capex to operating income (%): 36.301262384407686
Buffett classification: The Good
Stock price: 33.04
P/E ratio: 27.461587510031425
Shares outstanding: 359179944
Book value: 7652883000
P/B ratio: 1.5506973450084105
Market cap (USD): 11867305349.76
Debt to equity: 0.58539180593771
Current ratio: 0.5247944166646918
Quick ratio: 0.5247944166646918
Interest coverage ratio: 2.6363999486440606
COGS to revenue (%): 44.519572186584796
SG&A to revenue (%): 4.595637485718509
Free cash flow (dilution-adjusted): 579143000
Buyback yield (%): 0
Retained earnings: -394908000
Receivables turnover: 37.004398760142216
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.034175664633529
FCF margin (%): 35.67019071756985
Revenue growth (%): 8.927739991170949
Rule of 40 score: 44.597930708740805
Financial ratios for AMH — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 36.01
Shares outstanding: 359179944
Market cap (USD): 12934069783.439999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMH — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 35.35
Shares outstanding: 359179944
Market cap (USD): 12697011020.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMH — annual report dated 2024-12-31
Total revenue: 1728697000
Gross profit: 973493000
Operating income: 412893000
Net income: 468142000
Capital expenditures: 121751000
Operating cash flow: 811535000
Depreciation & amortization: 477010000
Net tangible assets: 7039737000
Owner earnings: 823401000
Return on net tangible assets (%): 11.696473888158037
Capex to operating income (%): 29.487300583928523
Buffett classification: The Good
Stock price: 35.35
P/E ratio: 27.12213606213499
Shares outstanding: 359179944
Book value: 7848630000
P/B ratio: 1.6177359641618982
Market cap (USD): 12697011020.4
Debt to equity: 0.6405029922419582
Current ratio: 0.9947327579538848
Quick ratio: 0.9947327579538848
Interest coverage ratio: 2.4970698695502294
COGS to revenue (%): 43.68631402727025
SG&A to revenue (%): 4.8354338556727985
Free cash flow (dilution-adjusted): 658800000
Buyback yield (%): 0
Retained earnings: -380632000
Receivables turnover: 35.678547841162384
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.180902673667596
FCF margin (%): 38.109628234444784
Revenue growth (%): 6.472756612599739
Rule of 40 score: 44.58238484704452
Financial ratios for AMH — quarterly report dated 2025-03-31
Total revenue: 459276000
Gross profit: 257565000
Operating income: 112966000
Net income: 128713000
Capital expenditures: 30942000
Operating cash flow: 223403000
Depreciation & amortization: 124928000
Net tangible assets: 7033610000
Owner earnings: 222699000
Return on net tangible assets (%): 3.166211945217321
Capex to operating income (%): 27.390542287059823
Buffett classification: The Good
Stock price: 36.03
P/E ratio: 25.13587085671222
Shares outstanding: 359179944
Book value: 7842111000
P/B ratio: 1.6502257341575504
Market cap (USD): 12941253382.32
Debt to equity: 0.6303066865541689
Current ratio: 0.329722505710259
Quick ratio: 0.329722505710259
Interest coverage ratio: 2.486813719015542
COGS to revenue (%): 43.919342617511035
SG&A to revenue (%): 4.283045488987015
Free cash flow (dilution-adjusted): 184800000
Buyback yield (%): 0
Retained earnings: -382384000
Receivables turnover: 8.743118218161051
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9061824495355139
FCF margin (%): 40.2372429650145
Rule of 40 score: 40.2372429650145
Financial ratios for AMH — quarterly report dated 2025-06-30
Total revenue: 457503000
Gross profit: 263002000
Operating income: 116055000
Net income: 123624000
Capital expenditures: 30747000
Operating cash flow: 271858000
Depreciation & amortization: 126939000
Net tangible assets: 7044927000
Owner earnings: 219816000
Return on net tangible assets (%): 3.1202026649814822
Capex to operating income (%): 26.493472922321317
Buffett classification: The Good
Stock price: 34.65
P/E ratio: 49.32128486745899
Shares outstanding: 359179944
Book value: 7845543000
P/B ratio: 1.586325517507201
Market cap (USD): 12445585059.6
Debt to equity: 0.6595706632415372
Current ratio: 1.073937164929089
Quick ratio: 1.073937164929089
Interest coverage ratio: 2.506425069649915
COGS to revenue (%): 42.51360100370927
SG&A to revenue (%): 4.373304655925754
Free cash flow (dilution-adjusted): 234638000
Buyback yield (%): 0
Retained earnings: -388735000
Receivables turnover: 9.00171178970565
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8852053660431545
FCF margin (%): 51.28665822956352
Revenue growth (%): -0.3860423797455125
Rule of 40 score: 50.90061584981801
Financial ratios for AMH — quarterly report dated 2025-09-30
Total revenue: 478464000
Gross profit: 263476000
Operating income: 116317000
Net income: 116801000
Capital expenditures: 32145000
Operating cash flow: 223254000
Depreciation & amortization: 126656000
Net tangible assets: 7040985000
Owner earnings: 211312000
Return on net tangible assets (%): 3.001171000932398
Capex to operating income (%): 27.63568523947488
Buffett classification: The Good
Stock price: 32.23
P/E ratio: 31.36054699088146
Shares outstanding: 359179944
Book value: 7837967000
P/B ratio: 1.4769607469794142
Market cap (USD): 11576369595.119999
Debt to equity: 0.6201592836509774
Current ratio: 0.38659976357805165
Quick ratio: 0.38659976357805165
Interest coverage ratio: 2.4132658353907757
COGS to revenue (%): 44.93295211342964
SG&A to revenue (%): 4.2851708801498125
Free cash flow (dilution-adjusted): 184884000
Buyback yield (%): 0
Retained earnings: -400445000
Receivables turnover: 8.424848570221158
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9193566961236719
FCF margin (%): 38.64115168539326
Revenue growth (%): 4.581609300922617
Rule of 40 score: 43.222760986315876
Financial ratios for AMH — quarterly report dated 2025-12-31
Total revenue: 454991000
Gross profit: 267429000
Operating income: 118787000
Net income: 144254000
Capital expenditures: 24377000
Operating cash flow: 145812000
Depreciation & amortization: 125818000
Net tangible assets: 6913469000
Owner earnings: 245695000
Return on net tangible assets (%): 3.553859863984347
Capex to operating income (%): 20.52160589963548
Buffett classification: The Great
Stock price: 31.42
P/E ratio: 21.982099137656995
Shares outstanding: 359179944
Book value: 7709506000
P/B ratio: 1.4638335893998915
Market cap (USD): 11285433840.480001
Debt to equity: 0.6631982645840083
Current ratio: 0.36679330309419766
Quick ratio: 0.36679330309419766
Interest coverage ratio: 2.623967307267506
COGS to revenue (%): 41.223232987026115
SG&A to revenue (%): 5.016362961025603
Free cash flow (dilution-adjusted): 115979000
Buyback yield (%): 0
Retained earnings: -387643000
Receivables turnover: 10.551984044156868
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9506286439750997
FCF margin (%): 25.490394315491955
Revenue growth (%): -4.905907236490101
Rule of 40 score: 20.584487079001853
Financial ratios for AMH — annual report dated 2025-12-31
Total revenue: 1850234000
Gross profit: 1051472000
Operating income: 464125000
Net income: 513392000
Capital expenditures: 118211000
Operating cash flow: 864327000
Depreciation & amortization: 504341000
Net tangible assets: 6913469000
Owner earnings: 899522000
Return on net tangible assets (%): 13.01115257767121
Capex to operating income (%): 25.46964718556423
Buffett classification: The Good
Stock price: 31.42
P/E ratio: 21.982099137656995
Shares outstanding: 359179944
Book value: 7709506000
P/B ratio: 1.4638335893998915
Market cap (USD): 11285433840.480001
Debt to equity: 0.6631982645840083
Current ratio: 0.36679330309419766
Quick ratio: 0.36679330309419766
Interest coverage ratio: 2.5061015777708184
COGS to revenue (%): 43.170863793444504
SG&A to revenue (%): 4.486243361650472
Free cash flow (dilution-adjusted): 720301000
Buyback yield (%): 1.32997102390187
Retained earnings: -387643000
Receivables turnover: 42.90994689116167
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.714299707753737
FCF margin (%): 38.930265036746704
Revenue growth (%): 7.030555383621305
Rule of 40 score: 45.96082042036801
Financial ratios for APYX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.82
Shares outstanding: 42110354
Market cap (USD): 539854738.28
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for APYX — annual report dated 2022-12-31
Total revenue: 44510000
Gross profit: 29131000
Operating income: -23562000
Net income: -23184000
Capital expenditures: 1010000
Operating cash flow: -20280000
Depreciation & amortization: 890000
Net tangible assets: 37582000
Owner earnings: -23304000
Return on net tangible assets (%): -62.00840828055985
Buffett classification: The Gruesome
Stock price: 2.34
Shares outstanding: 42110354
Book value: 37793000
P/B ratio: 2.6073142740719177
Market cap (USD): 98538228.36
Debt to equity: 0.021062101447357977
Current ratio: 3.6263291139240508
Quick ratio: 2.630801687763713
Interest coverage ratio: -1570.8
COGS to revenue (%): 34.551786115479665
R&D to revenue (%): 10.208941810829026
SG&A to revenue (%): 108.17569085598741
Free cash flow (dilution-adjusted): -27987000
Buyback yield (%): 0
Retained earnings: -35735000
Inventory turnover: 1.3036365177587523
Receivables turnover: 2.4394387811027074
Capitalized R&D asset: 4544000
ROCI (R&D-adjusted, %): -46.17298942334361
FCF margin (%): -62.87800494270951
Rule of 40 score: -62.87800494270951
Financial ratios for APYX — annual report dated 2023-12-31
Total revenue: 52349000
Gross profit: 33759000
Operating income: -19951000
Net income: -18713000
Capital expenditures: 6734000
Operating cash flow: -5249000
Depreciation & amortization: 692000
Net tangible assets: 26701000
Owner earnings: -24755000
Return on net tangible assets (%): -92.71188345005805
Buffett classification: The Gruesome
Stock price: 2.62
Shares outstanding: 42110354
Book value: 26922000
P/B ratio: 4.0981029448035065
Market cap (USD): 110329127.48
Debt to equity: 1.430094346631008
Current ratio: 5.522919937205652
Quick ratio: 4.74403453689168
Interest coverage ratio: -8.051251008878127
COGS to revenue (%): 35.51166211388947
R&D to revenue (%): 10.391793539513648
SG&A to revenue (%): 92.20806510153011
Free cash flow (dilution-adjusted): -10896000
Buyback yield (%): 0
Retained earnings: -54448000
Inventory turnover: 1.8734253753905068
Receivables turnover: 3.733081366326749
Capitalized R&D asset: 8484480
ROCI (R&D-adjusted, %): -23.790256330376632
Rosenberg metric: 1.0184859154929577
FCF margin (%): -20.814151177672926
Revenue growth (%): 17.61177263536284
Rule of 40 score: -3.202378542310086
Financial ratios for APYX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.24
Shares outstanding: 42110354
Market cap (USD): 52216838.96
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for APYX — annual report dated 2024-12-31
Total revenue: 48102000
Gross profit: 29360000
Operating income: -18845000
Net income: -23463000
Capital expenditures: 722000
Operating cash flow: -18047000
Depreciation & amortization: 599000
Net tangible assets: 14210000
Owner earnings: -23586000
Return on net tangible assets (%): -165.98170302603802
Buffett classification: The Gruesome
Stock price: 1.58
Shares outstanding: 42110354
Book value: 14335000
P/B ratio: 4.641392348796652
Market cap (USD): 66534359.32
Debt to equity: 2.7041506801534707
Current ratio: 5.264434287846283
Quick ratio: 4.558903087398564
Interest coverage ratio: -3.1902827154223803
COGS to revenue (%): 38.96303687996341
R&D to revenue (%): 10.560891439025404
SG&A to revenue (%): 89.65323687164775
Free cash flow (dilution-adjusted): -22782000
Buyback yield (%): 0
Retained earnings: -77911000
Inventory turnover: 2.4777895293495504
Receivables turnover: 3.107364341085271
Capitalized R&D asset: 10224320
ROCI (R&D-adjusted, %): -29.196114547776485
Rosenberg metric: -0.8086397058823529
FCF margin (%): -47.361856055881255
Revenue growth (%): -8.112857934248984
Rule of 40 score: -55.47471399013024
Financial ratios for APYX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.58
Shares outstanding: 42110354
Market cap (USD): 66534359.32
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for APYX — quarterly report dated 2025-03-31
Total revenue: 9430000
Gross profit: 5665000
Operating income: -3051000
Net income: -4150000
Capital expenditures: 55000
Operating cash flow: -702000
Depreciation & amortization: 138000
Net tangible assets: 10511000
Owner earnings: -4067000
Return on net tangible assets (%): -38.69279802112074
Buffett classification: The Gruesome
Stock price: 1.37
Shares outstanding: 42110354
Book value: 10644000
P/B ratio: 5.420066232619317
Market cap (USD): 57691184.980000004
Debt to equity: 3.6561443066516346
Current ratio: 5.452260778128286
Quick ratio: 4.64416403785489
Interest coverage ratio: -2.217296511627907
COGS to revenue (%): 39.925768822905624
R&D to revenue (%): 8.525980911983034
SG&A to revenue (%): 83.90243902439025
Free cash flow (dilution-adjusted): -1208000
Buyback yield (%): 0
Retained earnings: -82061000
Inventory turnover: 0.48991541964866625
Receivables turnover: 0.8097896092743667
Capitalized R&D asset: 804000
ROCI (R&D-adjusted, %): -4.8878610020600926
FCF margin (%): -12.810180275715801
Rule of 40 score: -12.810180275715801
Financial ratios for APYX — quarterly report dated 2025-06-30
Total revenue: 11373000
Gross profit: 7083000
Operating income: -2574000
Net income: -3738000
Capital expenditures: 265000
Operating cash flow: -1233000
Depreciation & amortization: 132000
Net tangible assets: 7253000
Owner earnings: -3871000
Return on net tangible assets (%): -53.3710188887357
Buffett classification: The Gruesome
Stock price: 2.25
Shares outstanding: 42110354
Book value: 7456000
P/B ratio: 12.707657792381974
Market cap (USD): 94748296.5
Debt to equity: 5.241148068669528
Current ratio: 4.724115086125307
Quick ratio: 3.948798031421541
Interest coverage ratio: -1.84781048097631
COGS to revenue (%): 37.72091796359799
R&D to revenue (%): 7.245229930537238
SG&A to revenue (%): 77.66640288402357
Free cash flow (dilution-adjusted): -2018000
Buyback yield (%): 0
Retained earnings: -85839000
Inventory turnover: 0.523681640625
Receivables turnover: 1.0111130867709814
Capitalized R&D asset: 1362680
ROCI (R&D-adjusted, %): -4.680374898165439
Rosenberg metric: 1.763681592039801
FCF margin (%): -17.743779126000174
Revenue growth (%): 20.604453870625665
Rule of 40 score: 2.8606747446254914
Financial ratios for APYX — quarterly report dated 2025-09-30
Total revenue: 12877000
Gross profit: 8297000
Operating income: -832000
Net income: -1955000
Capital expenditures: 519000
Operating cash flow: -3536000
Depreciation & amortization: 164000
Net tangible assets: 5848000
Owner earnings: -2310000
Return on net tangible assets (%): -39.500683994528046
Buffett classification: The Gruesome
Stock price: 2.14
Shares outstanding: 42110354
Book value: 6080000
P/B ratio: 14.821736440789476
Market cap (USD): 90116157.56
Debt to equity: 6.449342105263158
Current ratio: 4.44416104937147
Quick ratio: 3.6111313536163236
Interest coverage ratio: -0.5888181174805379
COGS to revenue (%): 35.56729051797779
R&D to revenue (%): 6.2203929486681675
SG&A to revenue (%): 64.67344878465481
Free cash flow (dilution-adjusted): -4585000
Buyback yield (%): 0
Retained earnings: -87823000
Inventory turnover: 0.5008201202843083
Receivables turnover: 0.9909195844555598
Capitalized R&D asset: 1618400
ROCI (R&D-adjusted, %): -1.751191879802411
Rosenberg metric: 1.4733009708737863
FCF margin (%): -35.60611943775724
Revenue growth (%): 13.22430317418447
Rule of 40 score: -22.381816263572773
Financial ratios for APYX — quarterly report dated 2025-12-31
Total revenue: 19164000
Gross profit: 11999000
Operating income: 11000
Net income: -1240000
Capital expenditures: 275000
Operating cash flow: -2530000
Depreciation & amortization: 221000
Net tangible assets: 14540000
Owner earnings: -1294000
Return on net tangible assets (%): -8.89958734525447
Capex to operating income (%): 2500
Buffett classification: The Gruesome
Stock price: 3.5
Shares outstanding: 42110354
Book value: 14831000
P/B ratio: 9.937714179758613
Market cap (USD): 147386239
Debt to equity: 2.652552086845122
Current ratio: 4.997521367521368
Quick ratio: 4.262307692307692
Interest coverage ratio: 0.007818052594171997
COGS to revenue (%): 37.38781047797954
R&D to revenue (%): 4.925902734293467
SG&A to revenue (%): 57.62888749739095
Free cash flow (dilution-adjusted): -3305000
Buyback yield (%): 0
Retained earnings: -89122000
Inventory turnover: 0.8329458265519647
Receivables turnover: 1.142346208869814
Capitalized R&D asset: 1752590
ROCI (R&D-adjusted, %): 0.1734262171341938
Rosenberg metric: 4.621722846441948
FCF margin (%): -17.24587768733041
Revenue growth (%): 48.82348373068261
Rule of 40 score: 31.5776060433522
Financial ratios for APYX — annual report dated 2025-12-31
Total revenue: 52844000
Gross profit: 33044000
Operating income: -6446000
Net income: -11105000
Capital expenditures: 1114000
Operating cash flow: -8001000
Depreciation & amortization: 655000
Net tangible assets: 14540000
Owner earnings: -11564000
Return on net tangible assets (%): -79.53232462173315
Buffett classification: The Gruesome
Stock price: 3.5
Shares outstanding: 42110354
Book value: 14831000
P/B ratio: 9.937714179758613
Market cap (USD): 147386239
Debt to equity: 2.652552086845122
Current ratio: 4.997521367521368
Quick ratio: 4.262307692307692
Interest coverage ratio: -1.1533369117910182
COGS to revenue (%): 37.468776019983345
R&D to revenue (%): 6.382938460373931
SG&A to revenue (%): 68.34645371281508
Free cash flow (dilution-adjusted): -11116000
Buyback yield (%): 0
Retained earnings: -89122000
Inventory turnover: 2.3017902813299234
Receivables turnover: 3.1499761564139246
Capitalized R&D asset: 8571800
ROCI (R&D-adjusted, %): -12.091951569411004
Rosenberg metric: 0.7251968503937007
FCF margin (%): -21.035500719097723
Revenue growth (%): 9.858217953515446
Rule of 40 score: -11.177282765582277
Financial ratios for AVR.V — annual report dated 2022-03-31
Total revenue: 0
Operating income: -97508
Net income: -97508
Capital expenditures: 0
Operating cash flow: -123760
Net tangible assets: 423889.6
Owner earnings: -97508
Return on net tangible assets (%): -23.00315931317966
Buffett classification: The Gruesome
Stock price: 0.072
Shares outstanding: 15046497
Book value: 423889.60000000003
P/B ratio: 2.5557309827841963
Market cap (USD): 1083347.784
Debt to equity: 0
Current ratio: 22.223343747496596
Quick ratio: 22.223343747496596
Free cash flow (dilution-adjusted): -135728
Buyback yield (%): 0
Retained earnings: -102307.2
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -23.003159313179655
Rule of 40 score: 0
Financial ratios for AVR.V — annual report dated 2023-03-31
Total revenue: 0
Operating income: -182482.22222222222
Net income: -182482.22222222222
Capital expenditures: 0
Operating cash flow: -90147.4074074074
Net tangible assets: 232245.18518518517
Owner earnings: -182482.22222222222
Return on net tangible assets (%): -78.5730916560085
Buffett classification: The Gruesome
Stock price: 0.08888888888888888
Shares outstanding: 15046497
Book value: 232245.18518518517
P/B ratio: 5.758855232815894
Market cap (USD): 1337466.4
Debt to equity: 0
Current ratio: 5.110157048845075
Quick ratio: 5.110157048845075
Free cash flow (dilution-adjusted): -112384.44444444444
Buyback yield (%): 0
Retained earnings: -277211.11111111107
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -78.5730916560085
Rule of 40 score: 0
Financial ratios for AVR.V — annual report dated 2024-03-31
Total revenue: 0
Operating income: -338450.37037037034
Net income: -338450.37037037034
Capital expenditures: 42644.444444444445
Operating cash flow: -364224.44444444444
Net tangible assets: 655447.4074074074
Owner earnings: -381094.8148148148
Return on net tangible assets (%): -58.142699247559484
Buffett classification: The Gruesome
Stock price: 0.058823529411764705
Shares outstanding: 15046497
Book value: 655447.4074074073
P/B ratio: 1.3503570977943986
Market cap (USD): 885088.0588235294
Debt to equity: 0
Current ratio: 7.537025817092464
Quick ratio: 7.537025817092464
Free cash flow (dilution-adjusted): -436101.48148148146
Buyback yield (%): 0
Retained earnings: -615661.4814814815
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -51.63654116950367
Rule of 40 score: 0
Financial ratios for AVR.V — quarterly report dated 2024-09-30
Capital expenditures: 2888.8888888888887
Buffett classification: The Gruesome
Stock price: 0.059259259259259255
Shares outstanding: 15046497
Market cap (USD): 891644.2666666666
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AVR.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -70412.58741258741
Net income: -70412.58741258741
Capital expenditures: 0
Operating cash flow: -49181.818181818184
Net tangible assets: 459818.1818181818
Owner earnings: -70412.58741258741
Return on net tangible assets (%): -15.313136843385951
Buffett classification: The Gruesome
Stock price: 0.06993006993006994
Shares outstanding: 15046497
Book value: 459818.1818181818
P/B ratio: 2.288301396112784
Market cap (USD): 1052202.5874125876
Debt to equity: 0
Current ratio: 6.121985379517661
Quick ratio: 6.121985379517661
Free cash flow (dilution-adjusted): -81675.52447552448
Buyback yield (%): 0
Retained earnings: -772673.4265734266
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.313136843385951
Rule of 40 score: 0
Financial ratios for AVR.V — annual report dated 2025-03-31
Total revenue: 0
Operating income: -228669.93006993007
Net income: -228669.93006993007
Capital expenditures: 12951.048951048951
Operating cash flow: -185587.4125874126
Net tangible assets: 460069.2307692308
Owner earnings: -241620.97902097902
Return on net tangible assets (%): -52.51839568079598
Buffett classification: The Gruesome
Stock price: 0.04195804195804196
Shares outstanding: 15046497
Book value: 460069.23076923075
P/B ratio: 1.3722316343390095
Market cap (USD): 631321.5524475524
Debt to equity: 0
Current ratio: 4.011143645594152
Quick ratio: 4.011143645594152
Free cash flow (dilution-adjusted): -234925.17482517485
Buyback yield (%): 0
Retained earnings: -809888.8111888112
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -49.70337392213698
Rule of 40 score: 0
Financial ratios for AVR.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -37215.38461538462
Net income: -37215.38461538462
Capital expenditures: 5145.454545454546
Operating cash flow: -25225.87412587413
Net tangible assets: 460069.2307692308
Owner earnings: -42360.83916083916
Return on net tangible assets (%): -9.207492335449666
Buffett classification: The Gruesome
Stock price: 0.04195804195804196
Shares outstanding: 15046497
Book value: 460069.23076923075
P/B ratio: 1.3722316343390095
Market cap (USD): 631321.5524475524
Debt to equity: 0
Current ratio: 4.011143645594152
Quick ratio: 4.011143645594152
Free cash flow (dilution-adjusted): -34264.33566433567
Buyback yield (%): 0
Retained earnings: -809888.8111888112
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.089083582738384
Rule of 40 score: 0
Financial ratios for AVR.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -10436.496350364963
Net income: -10436.496350364963
Capital expenditures: 24690.510948905106
Operating cash flow: -24645.25547445255
Net tangible assets: 482913.13868613134
Owner earnings: -35127.00729927007
Return on net tangible assets (%): -7.273980450157273
Buffett classification: The Gruesome
Stock price: 0.0437956204379562
Shares outstanding: 15046497
Book value: 482913.13868613134
P/B ratio: 1.3645739134903587
Market cap (USD): 658970.6715328466
Debt to equity: 0
Current ratio: 7.120557755954642
Quick ratio: 7.120557755954642
Free cash flow (dilution-adjusted): -49335.76642335766
Buyback yield (%): 0
Retained earnings: -855794.8905109488
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.1611539455645556
Rule of 40 score: 0
Financial ratios for AVR.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -17774.100719424463
Net income: -17774.100719424463
Capital expenditures: 0
Operating cash flow: -17805.755395683456
Net tangible assets: 458190.64748201444
Owner earnings: -17774.100719424463
Return on net tangible assets (%): -3.8791932609497795
Buffett classification: The Gruesome
Stock price: 0.06474820143884892
Shares outstanding: 15046497
Book value: 458190.6474820144
P/B ratio: 2.1262625591747333
Market cap (USD): 974233.618705036
Debt to equity: 0
Current ratio: 6.806498385289659
Quick ratio: 6.806498385289659
Free cash flow (dilution-adjusted): -17805.755395683456
Buyback yield (%): 0
Retained earnings: -861255.3956834533
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.8791932609497795
Rule of 40 score: 0
Financial ratios for BCH — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.69
Shares outstanding: 505085406
Market cap (USD): 5399362990.139999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BCH — annual report dated 2022-12-31
Total revenue: 3634697429.906542
Net income: 1689019859.8130841
Capital expenditures: 23251168.224299066
Operating cash flow: 150247663.55140188
Depreciation & amortization: 98370327.10280374
Net tangible assets: 6181547897.196261
Owner earnings: 1764139018.6915889
Return on net tangible assets (%): 28.53879073705377
Buffett classification: The Gruesome
Stock price: 15.09
P/E ratio: 4.512521704382719
Shares outstanding: 505085406
Book value: 6345136682.242996
P/B ratio: 1.2011937895474503
Market cap (USD): 7621738776.54
Debt to equity: 1.9159701198780341
Effective tax rate (%): 16.669010553253298
COGS to revenue (%): 0
SG&A to revenue (%): 33.0253485599754
Free cash flow (dilution-adjusted): 58978971.96261682
Buyback yield (%): 0
Retained earnings: 2725075934.579439
Receivables turnover: 1.3636063218579715
Capitalized R&D asset: 0
FCF margin (%): 1.6226652451819996
Rule of 40 score: 1.6226652451819996
Financial ratios for BCH — annual report dated 2023-12-31
Total revenue: 3357135105.8057513
Net income: 1553204693.4346175
Capital expenditures: 26132664.13456321
Operating cash flow: 1950835368.0593235
Depreciation & amortization: 104345270.39247604
Net tangible assets: 6682185973.955507
Owner earnings: 1631417299.6925304
Return on net tangible assets (%): 24.41442525022715
Buffett classification: The Gruesome
Stock price: 18.62
P/E ratio: 6.055023075499026
Shares outstanding: 505085406
Book value: 6875050868.149757
P/B ratio: 1.3679448254396742
Market cap (USD): 9404690259.720001
Debt to equity: 1.8930610191312152
Effective tax rate (%): 18.990991904564535
COGS to revenue (%): 0
SG&A to revenue (%): 30.448580671924834
Free cash flow (dilution-adjusted): 1852830529.9330802
Buyback yield (%): 0
Retained earnings: 3168968167.842286
Receivables turnover: 1.1648887849895428
Capitalized R&D asset: 0
FCF margin (%): 55.190824066890784
Revenue growth (%): -7.636462991856997
Rule of 40 score: 47.55436107503379
Financial ratios for BCH — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.06
Shares outstanding: 505085406
Market cap (USD): 11142184056.359999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BCH — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.76
Shares outstanding: 505085406
Market cap (USD): 9980487622.560001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BCH — annual report dated 2024-12-31
Total revenue: 3060000000
Net income: 1256833945.7391653
Capital expenditures: 16038657.069512255
Operating cash flow: 3718867468.666633
Depreciation & amortization: 95234308.14919212
Net tangible assets: 6355190013.590376
Owner earnings: 1336029596.818845
Return on net tangible assets (%): 21.022653830362074
Buffett classification: The Gruesome
Stock price: 19.76
P/E ratio: 7.940975541275907
Shares outstanding: 505085406
Book value: 6548443146.927063
P/B ratio: 1.5241008280332198
Market cap (USD): 9980487622.560001
Debt to equity: 1.8376688881728476
Effective tax rate (%): 21.086268241052743
COGS to revenue (%): 0
SG&A to revenue (%): 30.147178080641496
Free cash flow (dilution-adjusted): 3643523430.814919
Buyback yield (%): 0
Retained earnings: 3126338148.6887803
Receivables turnover: 1.046983257022224
Capitalized R&D asset: 0
FCF margin (%): 119.06939316388625
Revenue growth (%): -8.850853374709072
Rule of 40 score: 110.21853978917717
Financial ratios for BCH — quarterly report dated 2025-03-31
Total revenue: 847132068.882729
Net income: 358975925.96634436
Capital expenditures: 1873758.6485365694
Operating cash flow: 1421461466.2679791
Depreciation & amortization: 25805923.565488793
Net tangible assets: 5710703450.684243
Owner earnings: 382908090.8832966
Return on net tangible assets (%): 6.7050949885590265
Buffett classification: The Gruesome
Stock price: 24.97
P/E ratio: 8.783306675697823
Shares outstanding: 505085406
Book value: 5887945522.40435
P/B ratio: 2.1420005568716403
Market cap (USD): 12611982587.82
Debt to equity: 2.312445323388985
Effective tax rate (%): 19.371332486874167
COGS to revenue (%): 0
SG&A to revenue (%): 29.916097807309654
Free cash flow (dilution-adjusted): 1401403409.2149203
Buyback yield (%): 0
Retained earnings: 2640650850.121134
Receivables turnover: 0.25966743637527123
Capitalized R&D asset: 0
FCF margin (%): 165.4291533388899
Rule of 40 score: 165.4291533388899
Financial ratios for BCH — quarterly report dated 2025-06-30
Total revenue: 822736372.5383527
Net income: 331701664.67196167
Capital expenditures: 1876836.0352518768
Operating cash flow: 504687193.99412465
Depreciation & amortization: 25794799.260145795
Net tangible assets: 5878180829.0719185
Owner earnings: 355619627.8968556
Return on net tangible assets (%): 6.0498245671187165
Buffett classification: The Gruesome
Stock price: 28.67
P/E ratio: 20.966075613713237
Shares outstanding: 505085406
Book value: 6057435534.76226
P/B ratio: 2.3905823688783734
Market cap (USD): 14480798590.02
Debt to equity: 2.302465302855614
Effective tax rate (%): 20.878296661943246
COGS to revenue (%): 0
SG&A to revenue (%): 32.610883430731164
Free cash flow (dilution-adjusted): 488742247.85115874
Buyback yield (%): 0
Retained earnings: 2964422804.9178543
Receivables turnover: 0.25317194386523156
Capitalized R&D asset: 0
FCF margin (%): 59.404478052096266
Revenue growth (%): -2.8797984683251903
Rule of 40 score: 56.524679583771075
Financial ratios for BCH — quarterly report dated 2025-09-30
Total revenue: 743083507.7828673
Net income: 303556697.8257715
Capital expenditures: 376189.19311045244
Operating cash flow: -1236558749.7668247
Depreciation & amortization: 24527949.924347628
Net tangible assets: 5713742823.387982
Owner earnings: 327708458.5570087
Return on net tangible assets (%): 5.7354429257054464
Buffett classification: The Gruesome
Stock price: 28.56
P/E ratio: 14.50889328876852
Shares outstanding: 505085406
Book value: 5887977490.828445
P/B ratio: 2.449948087918106
Market cap (USD): 14425239195.359999
Debt to equity: 2.4703783917930773
Effective tax rate (%): 22.872106525671644
COGS to revenue (%): 0
SG&A to revenue (%): 34.17592823741233
Free cash flow (dilution-adjusted): -1256218003.1919081
Buyback yield (%): 0
Retained earnings: 3127152983.605198
Receivables turnover: 0.23921350533719973
Capitalized R&D asset: 0
FCF margin (%): -169.0547549548067
Revenue growth (%): -9.68145658976227
Rule of 40 score: -178.73621154456896
Financial ratios for BCH — annual report dated 2025-12-31
Total revenue: 3324784985.665711
Net income: 1317213369.7802074
Capital expenditures: 10708491.677222926
Operating cash flow: 917922305.9315065
Depreciation & amortization: 105684823.43267329
Net tangible assets: 7200322243.705135
Owner earnings: 1412189701.5356576
Return on net tangible assets (%): 19.612868059763038
Buffett classification: The Gruesome
Stock price: 35.82
P/E ratio: 13.735177350909284
Shares outstanding: 505085406
Book value: 7431436540.213791
P/B ratio: 2.4345440003447187
Market cap (USD): 18092159242.920002
Debt to equity: 1.9825570172284146
Effective tax rate (%): 21.172216270636874
COGS to revenue (%): 0
SG&A to revenue (%): 30.50545986490456
Free cash flow (dilution-adjusted): 832028801.920128
Buyback yield (%): 0
Retained earnings: 3616348867.702291
Receivables turnover: 0.9639426809663566
Capitalized R&D asset: 0
FCF margin (%): 25.02504088256202
Revenue growth (%): 8.65310410672258
Rule of 40 score: 33.678144989284604
Financial ratios for BCH — quarterly report dated 2025-12-31
Total revenue: 845239682.6455096
Net income: 287450274.462742
Capital expenditures: 6480432.02880192
Operating cash flow: 280996510.87850296
Depreciation & amortization: 26765117.674511634
Net tangible assets: 7200322243.705135
Owner earnings: 307734960.10845166
Return on net tangible assets (%): 4.273905384963683
Buffett classification: The Gruesome
Stock price: 35.82
P/E ratio: 14.115921940734971
Shares outstanding: 505085406
Book value: 7431436540.213791
P/B ratio: 2.4345440003447187
Market cap (USD): 18092159242.920002
Debt to equity: 1.9825570172284146
Effective tax rate (%): 21.784142034734653
COGS to revenue (%): 0
SG&A to revenue (%): -6.533362255394951
Free cash flow (dilution-adjusted): 252890192.67951196
Buyback yield (%): 0
Retained earnings: 3616348867.702291
Receivables turnover: 0.24505723204994795
Capitalized R&D asset: 0
FCF margin (%): 29.91934688726312
Revenue growth (%): 13.747603572503566
Rule of 40 score: 43.66695045976669
Financial ratios for BOE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.55
Shares outstanding: 55600125
Market cap (USD): 475381068.75000006
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BOE — annual report dated 2022-12-31
Total revenue: -108584716
Net income: -108682012
Capital expenditures: 0
Operating cash flow: 59930977
Net tangible assets: 688463885
Owner earnings: -108682012
Return on net tangible assets (%): -15.786160228288518
Buffett classification: The Gruesome
Stock price: 7.22
Shares outstanding: 55600125
Book value: 688463885
P/B ratio: 0.5830849101111527
Market cap (USD): 401432902.5
Debt to equity: 0
Free cash flow (dilution-adjusted): 59930977
Buyback yield (%): 3.0237304726161556
Retained earnings: -7640554
Receivables turnover: -63.58450170197391
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BOE — annual report dated 2023-12-31
Total revenue: 97388392
Net income: 96980193
Capital expenditures: 0
Operating cash flow: 54999782
Net tangible assets: 726489187
Owner earnings: 96980193
Return on net tangible assets (%): 13.349158492017581
Buffett classification: The Gruesome
Stock price: 8.09
P/E ratio: 4.638112147807337
Shares outstanding: 55600125
Book value: 726489187
P/B ratio: 0.6191489416483221
Market cap (USD): 449805011.25
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 0.5154402795766461
Free cash flow (dilution-adjusted): 54999782
Buyback yield (%): 2.717191159350384
Retained earnings: 75599791
Receivables turnover: 44.45578176639217
Capitalized R&D asset: 0
FCF margin (%): 56.474679241033165
Rule of 40 score: 56.474679241033165
Financial ratios for BOE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 704709199
Buffett classification: The Gruesome
Stock price: 9.45
Shares outstanding: 55600125
Book value: 704709199
P/B ratio: 0.7455858132625284
Market cap (USD): 525421181.24999994
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 127041967
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BOE — annual report dated 2024-12-31
Total revenue: 62709455
Net income: 62397807
Capital expenditures: 0
Operating cash flow: 83910682
Net tangible assets: 704709199
Owner earnings: 62397807
Return on net tangible assets (%): 8.85440506361263
Buffett classification: The Gruesome
Stock price: 9.45
P/E ratio: 8.420507170227953
Shares outstanding: 55600125
Book value: 704709199
P/B ratio: 0.7455858132625284
Market cap (USD): 525421181.24999994
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 0.8303915254884611
Free cash flow (dilution-adjusted): 83910682
Buyback yield (%): 7.0408594704898
Retained earnings: 127041967
Receivables turnover: 43.84693991707395
Capitalized R&D asset: 0
FCF margin (%): 133.80866091086264
Revenue growth (%): -35.608901931556694
Rule of 40 score: 98.19975897930595
Financial ratios for BOE — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 690828088
Buffett classification: The Gruesome
Stock price: 10.42
Shares outstanding: 55600125
Book value: 690828088
P/B ratio: 0.8386359972381435
Market cap (USD): 579353302.5
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 147862727
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BONE.V — annual report dated 2021-06-30
Total revenue: 0
Gross profit: -8193.548387096775
Operating income: -870566.1290322581
Net income: -883411.2903225806
Capital expenditures: 228519.35483870967
Operating cash flow: -865957.2580645161
Depreciation & amortization: 8193.548387096775
Net tangible assets: 7779911.29032258
Owner earnings: -1103737.0967741935
Return on net tangible assets (%): -14.187013907820905
Buffett classification: The Gruesome
Stock price: 0.11290322580645162
Shares outstanding: 278652206
Book value: 7779911.290322581
P/B ratio: 4.043842116119991
Market cap (USD): 31460732.935483873
Debt to equity: 0.009939059343283829
Current ratio: 0.43587809062777655
Quick ratio: 0.43587809062777655
Interest coverage ratio: -199.90777777777777
Free cash flow (dilution-adjusted): -1030020.1612903225
Buyback yield (%): 0
Retained earnings: -22101227.419354837
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.143718082520136
Rule of 40 score: 0
Financial ratios for BONE.V — annual report dated 2022-06-30
Total revenue: 0
Gross profit: -8568.992248062015
Operating income: -689258.1395348837
Net income: -836615.503875969
Capital expenditures: 33889.92248062015
Operating cash flow: -544327.1317829457
Depreciation & amortization: 8568.992248062015
Net tangible assets: 7179320.930232558
Owner earnings: -861936.4341085271
Return on net tangible assets (%): -12.005821197919433
Buffett classification: The Gruesome
Stock price: 0.06976744186046512
Shares outstanding: 278652206
Book value: 7179320.930232558
P/B ratio: 2.707895603263637
Market cap (USD): 19440851.58139535
Debt to equity: 0.012225897722615038
Current ratio: 0.1166843692099585
Quick ratio: 0.1166843692099585
Interest coverage ratio: -164.65611111111113
Free cash flow (dilution-adjusted): -544327.1317829457
Buyback yield (%): 0
Retained earnings: -22081206.201550387
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.554852041819666
Rule of 40 score: 0
Financial ratios for BONE.V — annual report dated 2023-06-30
Total revenue: 0
Gross profit: -8647.368421052632
Operating income: -685980.4511278195
Net income: -679612.7819548872
Capital expenditures: 194392.4812030075
Operating cash flow: -777990.2255639097
Depreciation & amortization: 8647.368421052632
Net tangible assets: 7354439.84962406
Owner earnings: -865357.8947368421
Return on net tangible assets (%): -11.766469131990752
Buffett classification: The Gruesome
Stock price: 0.045112781954887216
Shares outstanding: 278652206
Book value: 7354439.84962406
P/B ratio: 1.7092771805277462
Market cap (USD): 12570776.210526315
Debt to equity: 0.010939430480590467
Current ratio: 0.39267239424730455
Quick ratio: 0.39267239424730455
Interest coverage ratio: -168.95444444444445
Free cash flow (dilution-adjusted): -777990.2255639097
Buyback yield (%): 0
Retained earnings: -22096722.556390975
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.327433022147636
Rule of 40 score: 0
Financial ratios for BONE.V — annual report dated 2024-06-30
Total revenue: 0
Gross profit: -14069.343065693429
Operating income: -694506.5693430656
Net income: -708484.6715328466
Capital expenditures: 0
Operating cash flow: -668410.2189781021
Depreciation & amortization: 14069.343065693429
Net tangible assets: 7571875.182481751
Owner earnings: -694415.3284671532
Return on net tangible assets (%): -9.170982243259223
Buffett classification: The Gruesome
Stock price: 0.0656934306569343
Shares outstanding: 278652206
Book value: 7571875.182481752
P/B ratio: 2.417580709018362
Market cap (USD): 18305619.372262772
Debt to equity: 0.013515440206164398
Current ratio: 0.3522181294042281
Quick ratio: 0.3522181294042281
Interest coverage ratio: -175.71080332409971
Free cash flow (dilution-adjusted): -668410.2189781021
Buyback yield (%): 0
Retained earnings: -22160047.445255473
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.129320186241301
Rule of 40 score: 0
Financial ratios for BONE.V — quarterly report dated 2024-09-30
Total revenue: 0
Gross profit: -4288.888888888889
Operating income: -177021.48148148146
Net income: -182483.70370370368
Capital expenditures: 0
Operating cash flow: -199054.07407407407
Depreciation & amortization: 4288.888888888889
Net tangible assets: 7756864.444444444
Owner earnings: -178194.8148148148
Return on net tangible assets (%): -2.297253176087665
Buffett classification: The Gruesome
Stock price: 0.05185185185185185
Shares outstanding: 278652206
Book value: 7756864.444444444
P/B ratio: 1.8626898803229677
Market cap (USD): 14448632.903703703
Debt to equity: 0.012985583044389739
Current ratio: 0.3387205557522721
Quick ratio: 0.3387205557522721
Interest coverage ratio: -175.71985294117644
Free cash flow (dilution-adjusted): -199054.07407407407
Buyback yield (%): 0
Retained earnings: -22670828.148148146
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.27299077778973
Rule of 40 score: 0
Financial ratios for BONE.V — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: -4048.951048951049
Operating income: -157571.32867132867
Net income: -163365.03496503498
Capital expenditures: 0
Operating cash flow: -67123.77622377622
Depreciation & amortization: 4048.951048951049
Net tangible assets: 7211646.853146854
Owner earnings: -159316.08391608394
Return on net tangible assets (%): -2.2091498261117044
Buffett classification: The Gruesome
Stock price: 0.04195804195804196
Shares outstanding: 278652206
Book value: 7211646.853146854
P/B ratio: 1.6212248310449635
Market cap (USD): 11691700.951048952
Debt to equity: 0.0127604385097727
Current ratio: 0.12498386220379164
Quick ratio: 0.12498386220379164
Interest coverage ratio: -63.75976230899829
Free cash flow (dilution-adjusted): -67123.77622377622
Buyback yield (%): 0
Retained earnings: -21565895.104895107
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.1765505122346505
Rule of 40 score: 0
Financial ratios for BONE.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -4048.2517482517483
Operating income: -148781.1188811189
Net income: -151083.21678321678
Capital expenditures: 0
Operating cash flow: -335540.5594405595
Depreciation & amortization: 4048.2517482517483
Net tangible assets: 7393472.7272727275
Owner earnings: -147034.96503496502
Return on net tangible assets (%): -1.9887131590083331
Buffett classification: The Gruesome
Stock price: 0.027972027972027975
Shares outstanding: 278652206
Book value: 7393472.7272727275
P/B ratio: 1.0542362957460305
Market cap (USD): 7794467.300699302
Debt to equity: 0.01202194413405285
Current ratio: 0.22196123748634014
Quick ratio: 0.22196123748634014
Interest coverage ratio: -59.52909904868495
Free cash flow (dilution-adjusted): -335540.5594405595
Buyback yield (%): 0
Retained earnings: -21716978.32167832
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.0047494272871393
Rule of 40 score: 0
Financial ratios for BONE.V — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.029197080291970802
Shares outstanding: 278652206
Market cap (USD): 8135830.832116788
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BONE.V — annual report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.029197080291970802
Shares outstanding: 278652206
Market cap (USD): 8135830.832116788
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BONE.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -4165.467625899281
Operating income: -303945.3237410072
Net income: -307932.37410071946
Capital expenditures: 0
Operating cash flow: -243771.9424460432
Depreciation & amortization: 4165.467625899281
Net tangible assets: 7908155.395683453
Owner earnings: -303766.90647482016
Return on net tangible assets (%): -3.841185349501689
Buffett classification: The Gruesome
Stock price: 0.02877697841726619
Shares outstanding: 278652206
Book value: 7908155.395683453
P/B ratio: 1.0139872216424244
Market cap (USD): 8018768.517985612
Debt to equity: 0.01062394744847683
Current ratio: 0.42809844828273963
Quick ratio: 0.42809844828273963
Interest coverage ratio: -256.05090909090904
Free cash flow (dilution-adjusted): -377373.38129496406
Buyback yield (%): 0
Retained earnings: -22813403.597122304
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.8296059054850096
Rule of 40 score: 0
Financial ratios for BONE.V — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -4239.41605839416
Operating income: -171635.03649635034
Net income: -173056.93430656934
Capital expenditures: 0
Operating cash flow: -57568.61313868612
Depreciation & amortization: 4239.41605839416
Net tangible assets: 7893999.999999999
Owner earnings: -168817.51824817518
Return on net tangible assets (%): -2.1385548295943146
Buffett classification: The Gruesome
Stock price: 0.0364963503649635
Shares outstanding: 278652206
Book value: 7893999.999999999
P/B ratio: 1.2882934558077002
Market cap (USD): 10169788.540145984
Debt to equity: 0.014656886224222778
Current ratio: 0.11904887764541526
Quick ratio: 0.11904887764541526
Interest coverage ratio: -172.7700220426157
Free cash flow (dilution-adjusted): -62701.45985401459
Buyback yield (%): 0
Retained earnings: -23319502.91970803
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.1621003323422405
Rule of 40 score: 0
Financial ratios for BOSCH-HCIL.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.68904127653963
Shares outstanding: 27190884
Market cap (USD): 616935089.4216009
Buyback yield (%): 0
Retained earnings: 78885665.30396941
Capitalized R&D asset: 0
Rule of 40 score: 0